Tiziana Life Sciences Ltd
TLSA
$2.04
-$0.09-4.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 21.88% | 0.00% | -54.90% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 41.94% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -94.41% | 0.00% | 125.42% | 0.00% |
| Change in Net Operating Assets | 0.00% | 24.15% | 0.00% | -232.78% | 0.00% |
| Cash from Operations | 0.00% | -254.26% | 0.00% | -581.50% | 0.00% |
| Capital Expenditure | 0.00% | -20.00% | 0.00% | 64.29% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 0.00% | 57,700.00% | 0.00% | 64.29% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 33.33% | 0.00% | -4.35% | 0.00% |
| Issuance of Common Stock | 0.00% | 59.45% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 62.76% | 0.00% | 6,653.62% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 3,566.67% | 0.00% | 100.81% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 35.97% | 0.00% | 4,994.34% | 0.00% |